Clinical Trial Update: Impact of the Combined Treatment of Liposomed Polyphenols With G04CB02 on the ALS Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combined treatment of Liposomed Polyphenols with G04CB02 in amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• G04CB02
• Liposomed Polyphenols

Snippet

Sponsor: Fundación Universidad Católica de Valencia San Vicente Mártir | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED